Company intelligence / Profile preview

Cerbascience

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Cerbascience is an independent consultancy company founded and operated by Paul Moser since 2018. The firm provides expert advice and support in pharmacology, preclinical research, and translational science for pharmaceutical and biotechnology companies. Its founder has extensive experience in CNS pharmacology, animal model translatability, and early-stage drug development across pharma, biotech, CROs, and academic collaborations. There are no clinical results or pipeline as the company does not develop therapeutics.

Industry: Consulting

Partnerships

PAASP Network

Beyond the preview

Go deeper on Cerbascience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerbascience.

Explore the full profile